HIV type 1 phenotype, tropism, and sequence patterns: Association and preference

AIDS Research and Human Retroviruses

Volumn 21, Issue 3, 2005, Pages 234-238

  Dong, Xiao Nan ^a   Chen, Xi ^a   Chen, Yu ^a   Ablimit, Ablikim ^a   Ye, Zi ^a   Wu, Yi ^a   Chen, Ying Hua ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160;

AMINO ACID SEQUENCE; ARTICLE; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SYNCYTIUM; VIROGENESIS; VIRUS ISOLATION; VIRUS STRAIN; CHEMISTRY; HUMAN; PHYSIOLOGY; PLANT GROWTH;

GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; PHENOTYPE; RECEPTORS, CCR5; TROPISM;

EID: 16444381128     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.234     Document Type: Article

References (22)

1. Alkhatib G, Combadiere C, Broder CC, et al.: CC CKRS: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272(5270): 1955-1958.
2. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272(5263):872-877.
3. Berger EA, Doms RW, Fenyo EM, et al.: A new classification for HIV-1. Nature 1998;391(6664):240.
4. Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, and Paxton WA: N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001;276(16):13433-13441.
5. Hwang SS, Boyle TJ, Lyerly HK, and Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253(5015):71-74.
6. Shioda T, Levy JA, and Cheng-Mayer C: Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991;349(6305):167-169.
7. Groenink M, Fouchier RA, Broersen S, et al.: Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 1993;260(5113):1513- 1516.
8. Jansson M, Backstrom E, Scarlatti Q, et al.: Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2001;17(15):1405-1414.
9. Nabatov AA, Pollakis G, Linnemann T, Kliphius A, Chalaby MI, and Paxton WA: Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. J Virol 2004;78(1):524-530.
10. Ogert RA, Lee MK, Ross W, Buckler-White A, Martin MA, and Cho MW: N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J Virol 2001;75(13):5998-6006.
11. Shioda T, Oka S, Xin X, et al.: In vivo sequence variability of human immunodeficiency viras type 1 envelope gp120: Association of V2 extension with slow disease progression. J Virol 1997;71 (7):4871-4881.
12. Wang B, Spira TJ, Owen S, Lal RB, and Saksena NK: HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors. AIDS 2000;14(3):213-223.
13. Masciotra S, Owen SM, Rudolph D, et al.: Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression. AIDS 2002;16(14): 1887-1898.
14. Cornelissen M, Hogervorst E, Zorgdrager F, Hartman S, and Goudsmit J: Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites. AIDS Res Hum Retroviruses 1995;11(10):1169-1175.
15. Wang N, Zhu T, and Ho DD: Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: Lack of correlation with viral phenotype. J Virol 1995;69(4): 2708-2715.
16. Hughes ES, Bell JE, and Simmonds P: Investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env. J Gen Virol 1997;78(Pt, 11):2871-2882.
17. Wang B, Mikhail M, Dyer WB, Zaunders JJ, Kelleher AD, and Saksena NK: First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection. Virology 2003;312(1):135-150.
18. Fouchier RA, Broersen SM, Brouwer M, et al.: Temporal relationship between elongation of the HIV type 1 glycoprotein 120 V2 domain and the conversion toward a syncytium-inducing phenotype. AIDS Res Hum Retroviruses 1995;11(12):1473-1478.
19. Schuitemaker H, Fouchier RA, Broersen S, et al.: Envelope V2 configuration and HIV-1 phenotype: Clarification. Science 1995;68(5207):115.
20. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, and Hendrickson WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393(6686):648-659.
21. Wyatt R, Kwong PD, Desjardins E, et al.: The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 1998;393 (6686):705-711.
22. Rizzuto CD, Wyatt R, Hernandez-Ramos N, et al.: A conserved HIV gp!20 glycoprotein structure involved in chemokine receptor binding. Science 1998;280(5371):1949-1953.